A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium:: Identification of a novel gain of function mutation (Ser820Phe) in the calcium-sensing receptor

被引:20
作者
Nagase, T
Murakami, T
Tsukada, T
Kitamura, R
Chikatsu, N
Takeo, H
Takata, N
Yasuda, H
Fukumoto, S
Tanaka, Y
Nagata, N
Yamaguchi, K
Akatsu, T
Yamamoto, M
机构
[1] Niigata Univ Hlth & Welf, Sch Hlth Sci, Dept Hlth & Nutr, Niigata 9503198, Japan
[2] Natl Canc Ctr, Res Inst, Div Growth Factor, Tokyo 1040045, Japan
[3] Natl Def Med Coll, Dept Internal Med 3, Saitama 3598513, Japan
[4] Natl Def Med Coll, Dept Gen Med, Saitama 3598513, Japan
[5] Univ Tokyo, Branch Hosp, Tokyo 1128868, Japan
[6] Self Def Forces Cent Hosp, Dept Internal Med, Tokyo 1548532, Japan
关键词
D O I
10.1210/jc.87.6.2681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To date about 20 activating mutations in the calcium-sensing receptor (CaR) gene have been identified to cause autosomal dominant hypocalcemia (ADH) or sporadic hypoparathyroid. ism. We report a novel activating mutation in the CaR gene in a Japanese family with ADH. The proband, a 15-yr-old boy, and 5 other patients in 3 generations were asymptomatic, except for the proband's grandmother who had a history of seizures. They showed mild hypocalcemia (1.68-1.98 mmol/liter) with normal urinary calcium excretion and low normal serum PTH levels. Their serum magnesium concentrations were below normal in 3 adults and within the normal range in 3 teenagers. There was a significant positive correlation (r = 0.90; P < 0.05) between the serum calcium and magnesium concentrations of 6 affected members. Nucleotide sequencing revealed that the proband had a known polymorphism (Gly(990) Arg) and a novel heterozygous mutation substituting phenylalanine for serine at codon 820 (Ser(820)Phe) in the sixth transmembrane helix of the CaR. In other family members, the Ser(820)Phe mutation cosegregated with hypocalcemia. The mutation was not detected in 50 control subjects. The Gly(990)Arg polymorphism was observed in 8 of 9 family members with or without hypocalcemia and in 36 of 50 controls. The sensitivity of the Ser(820)Phe mutant CaR to calcium was assessed using transiently transfected HEK293 cells and measuring the increases in intracellular Ca2+ concentrations in response to the changes in extracellular Ca2+. The concentration-response curve of the mutant receptor was left-shifted, and its EC50 (2.5 mm) was significantly (P < 0.05) lower than that of the wildtype CaR (3.3 mM). We conclude that the Ser(820)Phe mutation in the CaR caused ADH in this family. The positive correlation between serum calcium and magnesium levels observed in this family may support the concept that renal CaR acts as a magnesium sensor as well as a calcium sensor.
引用
收藏
页码:2681 / 2687
页数:7
相关论文
共 30 条
[21]   DIVALENT-CATION METABOLISM - FAMILIAL HYPOCALCIURIC HYPER-CALCEMIA VERSUS TYPICAL PRIMARY HYPER-PARATHYROIDISM [J].
MARX, SJ ;
SPIEGEL, AM ;
BROWN, EM ;
KOEHLER, JO ;
GARDNER, DG ;
BRENNAN, MF ;
AURBACH, GD .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (02) :235-242
[22]  
Okzaki R, 1999, J CLIN ENDOCR METAB, V84, P363
[23]   Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells [J].
Pearce, SHS ;
Bai, M ;
Quinn, SJ ;
Kifor, O ;
Brown, EM ;
Thakker, RV .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (08) :1860-1866
[24]   A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor [J].
Pearce, SHS ;
Williamson, C ;
Kifor, O ;
Bai, M ;
Coulthard, MG ;
Davies, M ;
LewisBarned, N ;
McCredie, D ;
Powell, H ;
KendallTaylor, P ;
Brown, EM ;
Thakker, RV .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1115-1122
[25]   Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism [J].
Pearce, SHS ;
Trump, D ;
Wooding, C ;
Besser, GM ;
Chew, SL ;
Grant, DB ;
Heath, DA ;
Hughes, IA ;
Paterson, CR ;
Whyte, MP ;
Thakker, RV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2683-2692
[26]   AUTOSOMAL-DOMINANT HYPOCALCEMIA CAUSED BY A CA2+-SENSING RECEPTOR GENE MUTATION [J].
POLLAK, MR ;
BROWN, EM ;
ESTEP, HL ;
MCLAINE, PN ;
KIFOR, O ;
PARK, J ;
HEBERT, SC ;
SEIDMAN, CE ;
SEIDMAN, JG .
NATURE GENETICS, 1994, 8 (03) :303-307
[27]   MUTATIONS IN THE HUMAN CA2+-SENSING RECEPTOR GENE CAUSE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM [J].
POLLAK, MR ;
BROWN, EM ;
CHOU, YHW ;
HEBERT, SC ;
MARX, SJ ;
STEINMANN, B ;
LEVI, T ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1993, 75 (07) :1297-1303
[28]   Familial hypoparathyroidism: Identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor [J].
Watanabe, T ;
Bai, M ;
Lane, CR ;
Matsumoto, S ;
Minamitani, K ;
Minagawa, M ;
Niimi, H ;
Brown, EM ;
Yasuda, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2497-2502
[29]   Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: Is it possible to differentiate the two disorders? [J].
Yamamoto, M ;
Akatsu, T ;
Nagase, T ;
Ogata, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4583-4591
[30]   The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions [J].
Zhang, ZX ;
Sun, S ;
Quinn, SJ ;
Brown, EM ;
Bai, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :5316-5322